Logo
ONCOLOGY RADIOPHARMACEUTICALS MARKET ANALYSIS
  2. / Market Insights
  3. Oncology Radiopharmaceuticals Market Analysis
We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image

ONCOLOGY RADIOPHARMACEUTICALS MARKET ANALYSIS

Oncology Radiopharmaceuticals Market, by Test Type (Radium-223 dichloride, Sodium iodide I-131, Lobenguane iodine-131, Lutetium-177, Yttrium-90, Fludeoxyglucose F 18, Gallium Citrate Ga 67, Technetium-99m, and Others), by Route of Administration (Oral and Intravenous), by Application (Diagnosis and Treatment), by End User (Diagnostic Centres, Hospitals and Clinics, and Research Institutes), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

  • Published In : Dec 2021
  • Code : CMI4834
  • Pages :202
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Market Challenges And Opportunities

Restraints & Challenges:

  • Lack of skilled professionals

Challenges that hamper the growth of the market...

Market Drivers:

  • Increasing demand for radiopharmaceuticals in cancer therapy
  • Shift towards combination therapies

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Press Release

Oncology Radiopharmaceuticals Market to Surpass US$ 5,206.8 Million by 2028
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.